UK REACH deadlines extended: what the new registration timeline means for industry

13 Apr 2026
UK REACH deadlines extended: what the new registration timeline means for industry

The UK Government has formally confirmed that Option 1 will be implemented under UK REACH, following the publication of the Summary of responses and government response. The deadlines for submitting full UK REACH registration have been extended to October 2029, October 2030, and October 2031, depending on the tonnage band and hazard profile.  

This decision provides long-awaited clarity for industry, providing companies additional time to prepare for full UK REACH compliance, while maintaining current regulatory obligations.  

What this means for the industry and registrants? 

Although these revised timelines reduce immediate pressure, the underlying legal obligations for UK REACH are still relevant. Companies placing substances on the Great Britain (GB) market must still ensure that their substances are covered by a valid registration or notification, and that the information held by authorities accurately reflects the current activities.  

Failure to maintain accurate registrations can lead to supply chain disruption, loss of market access and potential enforcement action from regulators. Companies that rely on outdated notifications may risk facing difficulties placing their substances on the GB market.  

Since the submission of Downstream User Import Notifications (DUINs) in 2021, many companies may have changed suppliers, tonnages, uses and market presence. Where these changes have occurred, existing notifications may no longer be valid or provide the correct coverage for the company’s UK product portfolio.  

The extended deadlines therefore create an opportunity to reassess your existing UK REACH registrations and confirm that compliance remains correct and fit for purpose.  

Using the extension to reassess your UK REACH portfolio 

With the confirmation of Option 1, companies now have a further transitional period to review their regulatory portfolios under UK REACH. This additional time allows businesses to confirm which substances they intend to continue placing on the GB market, and where future compliance effort should be focused. 

Regulators are increasingly expecting companies to demonstrate active management of their UK REACH obligations, rather than relying only on historic notifications made in the transition from EU REACH. 

This period is an ideal opportunity to: 

  • Check whether DUINs and registrations still reflect current imports or manufacture 

  • Identify substances that may no longer require registration 

  • Align regulatory priorities with commercial decision-making 

  • Assess whether taking on a Lead Registrant role may be required 

In many cases, the former EU REACH lead registrant is no longer active in the GB market, meaning UK-based manufacturers or importers may need to coordinate future submissions. This role involves managing co-registrants, confirming substance identity and data sharing, and may require early planning where registrant groups are small, or access to existing data is limited. 

Early portfolio review can significantly reduce future costs and prevent last-minute decision making as new deadlines approach. 

Supply chains, substance risk and regulatory focus 

Businesses manufacturing or importing substances into GB should use this time to confirm their understanding of their supply chains is accurate and up-to-date. This includes verifying the correct UK REACH duty holder for each substance and confirming whether responsibilities have shifted due to post-Brexit commercial changes.  

Existing DUINs and registrations should be reviewed to ensure they still reflect current import volumes, uses, and substance identities. Where discrepancies exist, these should be addressed sooner rather than later to avoid future compliance issues 

Regulatory focus will continue to prioritise substance risk along with tonnage bands. Substances with more complex and hazardous profiles are therefore likely to remain a priority within the UK REACH framework. For businesses, this reinforces the importance of planning ahead for higher risk substances to avoid unnecessary regulatory and cost implications later 

The next steps ahead of the extension 

The confirmation of extended UK REACH deadlines creates an opportunity for companies to take a more structured and informed approach to compliance. Reviewing existing UK REACH portfolios now allows businesses to identify potential gaps, confirm which substances remain commercially relevant, and ensure that regulatory responsibilities are clearly understood across increasingly complex supply chains.  

At the same time, the extension places greater emphasis on active compliance management. Companies that use this period to reassess notifications, confirm duty-holder roles, and prioritise substances based on both regulatory and commercial considerations will be better prepared to maintain continuity of supply and manage long-term compliance costs as the UK REACH framework continues to evolve. 

The government has also confirmed that the statutory timelines for the Health and Safety Executive’s compliance checks, covering a minimum of 20% submitted dossiers, will move in line with the revised submission dates. This ensures that regulatory scrutiny is applied once meaningful data is available and reinforces that the deadlines are intended to support effective regulatory compliance, rather than simply delaying enforcement. 

Key Takeaway 

The extension of UK REACH deadlines gives companies additional time to plan ahead, but it does not remove the responsibility to ensure current portfolios are correctly registered and covered.  

At Ricardo, we can support businesses navigate UK REACH compliance, including portfolio reviews, DUIN and NRES registrations, supply chain tacking and any other queries you may have. If you would like to discuss how the extended deadlines may affect your business, contact our chemical regulatory and compliance experts 

Contact us